Silva, B. C., Cusano, N. E., & Bilezikian, J. P. (2024). Primary hyperparathyroidism. Best Practice & Research Clinical Endocrinology & Metabolism, 38(1), 101247. https://doi.org/10.1016/j.beem.2018.09.013

Bandeira, F., Nóbrega, J. de M., Oliveira, L. B. de, & Bilezikian, J. (2022). Medical management of primary hyperparathyroidism. Archives of Endocrinology and Metabolism, 66(5), 689–693. https://doi.org/10.20945/2359-3997000000558

Bilezikian, J. P., Khan, A. A., Silverberg, S. J., Fuleihan, G. E.-H., Marcocci, C., Minisola, S., Perrier, N., Sitges-Serra, A., Thakker, R. V., Guyatt, G., Mannstadt, M., Potts, J. T., Clarke, B. L., & Brandi, M. L. (2020). Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research, 37(11), 2293–2314. https://doi.org/10.1002/jbmr.4677

Ye, Z., Silverberg, S. J., Sreekanta, A., Tong, K., Wang, Y., Chang, Y., Zhang, M., Guyatt, G., Tangamornsuksun, W., Zhang, Y., Manja, V., Bakaa, L., Couban, R. J., Brandi, M. L., Clarke, B., Khan, A. A., Mannstadt, M., & Bilezikian, J. P. (2020). The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Bone and Mineral Research, 37(11), 2351–2372. https://doi.org/10.1002/jbmr.4685

El-Hajj Fuleihan, G., Chakhtoura, M., Cipriani, C., Eastell, R., Karonova, T., Liu, J.-M., Minisola, S., Mithal, A., Moreira, C. A., Peacock, M., Schini, M., Silva, B., Walker, M., El Zein, O., & Marcocci, C. (2020). Classical and Nonclassical Manifestations of Primary Hyperparathyroidism. Journal of Bone and Mineral Research, 37(11), 2330–2350. https://doi.org/10.1002/jbmr.4679

Yao, L., Guyatt, G., Ye, Z., Bilezikian, J. P., Brandi, M. L., Clarke, B. L., Mannstadt, M., & Khan, A. A. (2020). Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism. Journal of Bone and Mineral Research, 37(11), 2404–2410. https://doi.org/10.1002/jbmr.4687

Bilezikian, J. P., Silverberg, S. J., Bandeira, F., Cetani, F., Chandran, M., Cusano, N. E., Ebeling, P. R., Formenti, A. M., Frost, M., Gosnell, J., Lewiecki, E. M., Singer, F. R., Gittoes, N., Khan, A. A., Marcocci, C., Rejnmark, L., Ye, Z., Guyatt, G., & Potts, J. T. (2020). Management of Primary Hyperparathyroidism. Journal of Bone and Mineral Research, 37(11), 2391–2403. https://doi.org/10.1002/jbmr.4682

Walker, M. D., & Shane, E. (2022). Hypercalcemia. JAMA, 328(16), 1624. https://doi.org/10.1001/jama.2022.18331

Chandran, M., Yeh, L. T. L., de Jong, M. C., Bilezikian, J. P., & Parameswaran, R. (2022). Cognitive deficits in primary hyperparathyroidism – what we know and what we do not know: A narrative review. Reviews in Endocrine and Metabolic Disorders, 23(5), 1079–1087. https://doi.org/10.1007/s11154-022-09750-9

Chandran, M., Bilezikian, J. P., Lau, J., Rajeev, R., Yang, S. P., Samuel, M., & Parameswaran, R. (2022). The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies. Reviews in Endocrine and Metabolic Disorders, 23(3), 485–501. https://doi.org/10.1007/s11154-021-09694-6